IP Library › Granted Patent US 9,540,380
Granted Patent B2
US 9,540,380 · App. 14/334,073 · Granted Jan 10, 2017

Imidazotriazinone compounds

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,540,380
App. No.
14/334,073
Granted
Jan 10, 2017
Kind
B2
Abstract

The present invention provides imidazotriazinone compounds which are inhibitors of phosphodiesterase 9. The present invention further provides processes, pharmaceutical compositions, pharmaceutical preparations and pharmaceutical use of the compounds in the treatment of PDE9 associated diseases or disorders in mammals, including humans.

Claims (1)

1. (+)-2-((3,4-trans)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl)-7-(tetrahydro-2H-pyran-4-yl)imidazo[5,1-f][1,2,4]triazin-4(3H)-one or a pharmaceutically acceptable salt thereof.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 27, 2016
From: FORUM PHARMACEUTICALS INC.
To: IRONWOOD PHARMACEUTICALS, INC.
Reel/Frame 040152/0212 →
CHANGE OF NAME Recorded Oct 18, 2016
From: ENVIVO PHARMACEUTICALS, INC.
To: FORUM PHARMACEUTICALS INC.
Reel/Frame 040138/0717 →
RELEASE OF SECURITY INTEREST Recorded Oct 12, 2016
From: FMR LLC
To: FORUM PHARMACEUTICALS INC.
Reel/Frame 039993/0853 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 16, 2016
From: CHESWORTH, RICHARD; SHAPIRO, GIDEON
To: FORUM PHARMACEUTICALS INC.
Reel/Frame 040027/0838 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 16, 2016
From: KOENIG, GERHARD
To: FORUM PHARMACEUTICALS INC.
Reel/Frame 040027/0902 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 16, 2016
From: RIPKA, AMY
To: ENVIVO PHARMACEUTICALS, INC.
Reel/Frame 040028/0013 →
SECURITY INTEREST Recorded Jul 5, 2016
From: FORUM PHARMACEUTICALS INC.
To: FMR LLC
Reel/Frame 039254/0828 →